Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT00232050
Eligibility Criteria:
Inclusion Criteria:
* Allergic asthma patients
* Inadequately controlled patients
Exclusion Criteria:
* \- History of severe anaphylactoid or anaphylactic reactions
* Previous treatment with omalizumab
* History of cancer or cancer
Other protocol-defined exclusion criteria may apply
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00232050
Study Brief:
Protocol Section:
NCT00232050